Status:

COMPLETED

The Retain Your Brain Health Study (RetainYourBrain.com)

Lead Sponsor:

Retain Health, Inc

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Alzheimer Disease

Dementia

Eligibility:

All Genders

53-105 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to test a cell phone-based online program that provides Alzheimer's risk assessments and memory tests over a 6-month period. The main question it aims to answer is w...

Detailed Description

Alzheimer's disease (AD) is a public health crisis with few effective treatments. Most people are unaware that AD begins in the brain decades before the first symptoms of memory loss begin. That leave...

Eligibility Criteria

Inclusion

  • be at least 53 years of age
  • have a family history of Alzheimer's Disease (AD)
  • have a compatible phone/device (phone allowing text messages and with internet access, and/or tablet device with the same capabilities)
  • a minimum of one of the following risk factors: body mass index (BMI) of \< 25 kg/m2, history of pre-diabetes/diabetes, high blood pressure, high cholesterol, smoking, low physical activity, low fish intake (\< 3 times per month), high alcohol intake (\< 7 servings per week for a women and \<14 servings a week for men), diagnosed with mild or moderate depression.

Exclusion

  • have a diagnosis of dementia due to AD
  • other dementia
  • women who are currently pregnant or who plan on becoming pregnant in the next 6 months
  • BMI \<18.5 kg/m2
  • consuming \>35 alcoholic drinks/week for men or \>28 alcoholic drinks/week for women
  • severe depression (PHQ-9 score of more than 15)
  • current treatment for cancer
  • diagnosis of Parkinson's disease, amyotrophic lateral sclerosis, Lewy body dementia, frontotemporal disorders, multiple sclerosis, or other neurodegenerative disease
  • current treatment for an eating disorder
  • currently prescribed insulin for type I or II diabetes
  • inability to give informed consent or complete identity verification
  • participating in another AD trial.

Key Trial Info

Start Date :

December 7 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 16 2024

Estimated Enrollment :

992 Patients enrolled

Trial Details

Trial ID

NCT06027320

Start Date

December 7 2023

End Date

September 16 2024

Last Update

November 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Retain Health, Inc.

Bedford, Massachusetts, United States, 01730